Evaluation of Nano Bioactive Glass Combined With i-PRF Scaffold in Vital Pulp Treatments
Short Term Clinical and Radiographic Evaluation of Nano Bioactive Glass Combined With i-PRF Scaffold in Vital Pulp Treatments in Mature Permanent Mandibular Molars: A Triple Blinded "Randomized Controlled Trial"
1 other identifier
interventional
30
1 country
1
Brief Summary
With consideration of the previous studies regarding the properties of i-PRF, it will be used in combination with another bioactive material: (Nano-BAG) versus using of i-PRF only as a pulpotomy material with using a premixed bioceramic putty as a coronal sealing material in both cases, to evaluate if there is a difference in the success rate of pulpotomy in case of using Nano-BAG in combination with i-PRF So, in this study the investigators will use Nano-BAG in combination with i-PRF as a material for pulpotomy in cases of mature permanent mandibular molars and compare its outcomes with using i-PRF only and in both cases pulpotomy material will be covered with a layer of premixed bioceramic putty for coronal sealing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 22, 2023
CompletedFirst Posted
Study publicly available on registry
June 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedJune 15, 2023
June 1, 2023
1 year
May 22, 2023
June 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pain measurement (change is being assessed)
Measurement of the change in pain intensity using Visual Analogue Scale from 0 to 10 where higher scores mean higher pain intensity
After 24 hours and up to 7 days for postoperative pain evaluation using Visual Analogue Scale.
Secondary Outcomes (2)
Radiographic assesment (change is being assessed)
at 1 month , 3 months and 6 months
Tooth sensibility (change is being assessed)
at 1 month , 3 months and 6 months
Study Arms (2)
Control group
EXPERIMENTALAfter control of bleeding in teeth allocated to the control group i-PRF is to be injected first. The i-PRF will be injected into the root canal to a level 3 mm below the cementoenamel junction (CEJ) then a layer of premixed bioceramic putty is to be added for coronal sealing.
Intervention group
ACTIVE COMPARATORAfter control of bleeding in teeth allocated to the intervention group, i-PRF is to be mixed with Nano bioactive glass (Nano-BAG) powder to a putty consistency and injected into the root canal to a level 3 mm below the cementoenamel junction (CEJ), then a layer of premixed bioceramic putty is to be added for coronal sealing.
Interventions
Performing pulpotomy for mature teeth that involves removal of the coronal pulp tissue that is diseased or inflammed followed by placement of a biocompatible material with the intent of maintaining the vitality of the remaining radicular pulp tissue.
Eligibility Criteria
You may qualify if:
- Patients suffering from symptomatic irreversible pulpitis.
- Tooth should give positive response to cold test
- Heamostatis should be achieved after complete pulpotomy
- Diagnosis is irreversible pulpitis with/without apical periodontitis
- The tooth is restorable and free from advanced periodontal disease
- Tooth is free from cracks or splits
- Patients should be free from any systemic disease that may affect normal healing and predictable outcomes.
- Patients who will agree to the consent and will commit to follow-up period.
- Patients with mature root (closed apices)
- Teeth with no periapical lesion, resorption or widening.
- Soft tissues around the tooth are normal with no swelling or sinus tract
- Mandibular posterior teeth only will be involved.
You may not qualify if:
- Patients with immature root apices.
- Patients with any systemic disease that may affect normal healing.
- Patients with periapical lesions or infections.
- If heamostasis couldn't be achieved within 5-10 minutes
- Pregnant females.
- Patients who could/would not participate in a 6 months follow-up.
- Patients with fistula or swelling
- Patients with necrotic pulp.
- Patients with old age.
- Badly destructed teeth
- Teeth that are non-restorable
- Teeth that require post and core build up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of oral and dental medicine - Cairo University
Cairo, 11511, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- * The participant will be blinded to the materials will be used during the pulpotomy process. * The outcome assessors will be blinded. * The operator will not be blinded for both materials during pulpotomy procedure as the two materials having different colors and different handling techniques.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 22, 2023
First Posted
June 15, 2023
Study Start
March 1, 2023
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
June 15, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share